US 12,357,841 B2
Light therapy treatment
Maik Huettemann, Grosse Pointe Park, MI (US); John Kamholz, Coralville, IA (US); Icksoo Lee, Cheonan-Si (KR); Karin Przyklenk, Grosse Pointe Park, MI (US); Lawrence Grossman, Ann Arbor, MI (US); and Thomas H. Sanderson, Plymouth, MI (US)
Assigned to Wayne State University, Detroit, MI (US)
Filed by Wayne State University, Detroit, MI (US)
Filed on Apr. 27, 2021, as Appl. No. 17/241,656.
Application 14/473,105 is a division of application No. 12/771,137, filed on Apr. 30, 2010, granted, now 8,945,196, issued on Feb. 3, 2015.
Application 17/241,656 is a continuation of application No. 16/019,756, filed on Jun. 27, 2018, granted, now 11,020,604.
Application 16/019,756 is a continuation of application No. 14/709,869, filed on May 12, 2015, granted, now 10,071,261, issued on Sep. 11, 2018.
Application 14/709,869 is a continuation in part of application No. 14/473,105, filed on Aug. 29, 2014, granted, now 9,610,460, issued on Apr. 4, 2017.
Claims priority of provisional application 61/215,105, filed on May 1, 2009.
Prior Publication US 2021/0252302 A1, Aug. 19, 2021
This patent is subject to a terminal disclaimer.
Int. Cl. A61N 5/06 (2006.01)
CPC A61N 5/06 (2013.01) [A61N 5/0613 (2013.01); A61N 2005/0626 (2013.01); A61N 2005/0643 (2013.01); A61N 2005/0647 (2013.01); A61N 2005/0652 (2013.01); A61N 2005/0659 (2013.01)] 13 Claims
OG exemplary drawing
 
1. A method of treating reperfusion injury in a tissue of a subject in need thereof, the method comprising:
selectively applying light via light sources, to the tissue to reduce ischemic reperfusion injury resulting from an ischemic event, that inhibits electron transfer from cytochrome c to cytochrome c oxidase (CcO) to molecular oxygen to attenuate creation of reactive oxygen species, the light having wavelengths in a first wavelength range of 730-770 nm and a second wavelength range of 930-970 nm, wherein selectively applying light in the first wavelength range and the second wavelength range avoids outputting light outside the first wavelength range and the second wavelength range to avoid activation of CcO.